Hypertrophic Obstructive Cardiomyopathy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
Condition: Hypertrophic Obstructive Cardiomyopathy Interventions: Drug: Esmolol; Drug: Placebo Sponsor: Meshalkin Research Institute of Pathology of Circulation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials
